Heron Therapeutics Stock News

Welcome to Seeking Alpha's Stocks to Watch - a preview of key events scheduled for the next week. Follow this account and turn the e-mail alert on to receive th

Revance Therapeutics (NASDAQ:RVNC) and Heron Therapeutics (NASDAQ:HRTX) are both small-cap medical companies, but which is the superior business? We will contrast the two companies based on the streng

Noteworthy events during the week of March 22 - 28 for healthcare investors (some could be canceled/postponed due to COVID-19).SUNDAY (3/22): European Society for Blood and Marrow Transplantation Annu

Bank of Montreal Can trimmed its position in shares of Heron Therapeutics Inc (NASDAQ:HRTX) by 51.5% during the fourth quarter, according to the company in its most recent Form 13F filing with the Sec

Disruptions in clinical trials and delayed regulatory decisions could slow the rate of new drug approvals.

ArrowMark Colorado Holdings LLC reduced its position in shares of Heron Therapeutics Inc (NASDAQ:HRTX) by 1.4% in the 4th quarter, according to the company in its most recent 13F filing with the Secur

Heron Therapeutics Inc (NASDAQ:HRTX)’s stock price fell 10.9% during trading on Wednesday . The company traded as low as $13.62 and last traded at $13.64, 1,799,235 shares traded hands during mid-da

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech stocks that hit 52-week highs March 12.) Masimo...

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week highs on March 11) Bicycle Therapeutics...

Franklin Resources Inc. grew its holdings in shares of Heron Therapeutics Inc (NASDAQ:HRTX) by 19.6% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and

Analysts expect that Heron Therapeutics Inc (NASDAQ:HRTX) will announce sales of $20.89 million for the current fiscal quarter, according to Zacks Investment Research. Four analysts have provided esti

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech stocks that hit 52-week highs March 9.) Arcutis...

Mackay Shields LLC trimmed its position in Heron Therapeutics Inc (NASDAQ:HRTX) by 19.0% during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Excha

Heron Therapeutics Inc (NASDAQ:HRTX) – Stock analysts at Cantor Fitzgerald reduced their FY2020 earnings per share (EPS) estimates for shares of Heron Therapeutics in a research report issued on Thu

Charles Schwab Investment Management Inc. lifted its stake in Heron Therapeutics Inc (NASDAQ:HRTX) by 15.3% during the fourth quarter, according to its most recent disclosure with the Securities & Exc